In recent guidance, we wrote about what companies should do to minimize the risk of federal criminal penalties when doing business with or investing in cannabis industry companies. See Minimizing the Risks of Doing Business With Companies in the Cannabis Industry. One principle we stressed is the need to know your potential partners in the cannabis industry to ensure that they fully comply with the drug laws of the state(s) in which they operate. A recent decision by the U.S. Court of Appeals for the Ninth Circuit, United States v. Gilmore, 886 F.3d 1288 (2018), demonstrates the importance of such due diligence. To read the full article click here.